nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP1A2—Dacarbazine—muscle cancer	0.119	0.143	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—muscle cancer	0.109	0.13	CbGbCtD
Ranitidine—ABCB1—Dactinomycin—muscle cancer	0.0905	0.108	CbGbCtD
Ranitidine—CYP3A5—Vincristine—muscle cancer	0.0856	0.103	CbGbCtD
Ranitidine—CYP3A5—Etoposide—muscle cancer	0.0784	0.0941	CbGbCtD
Ranitidine—CYP1A2—Etoposide—muscle cancer	0.0584	0.07	CbGbCtD
Ranitidine—ABCB1—Vincristine—muscle cancer	0.0557	0.0668	CbGbCtD
Ranitidine—ABCB1—Etoposide—muscle cancer	0.051	0.0612	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—muscle cancer	0.0348	0.0418	CbGbCtD
Ranitidine—ABCB1—Methotrexate—muscle cancer	0.0337	0.0404	CbGbCtD
Ranitidine—CYP3A4—Vincristine—muscle cancer	0.0334	0.04	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—muscle cancer	0.0328	0.0393	CbGbCtD
Ranitidine—CYP3A4—Etoposide—muscle cancer	0.0306	0.0367	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—muscle cancer	0.0209	0.025	CbGbCtD
Ranitidine—Nephropathy—Etoposide—muscle cancer	0.00363	0.0218	CcSEcCtD
Ranitidine—Bone marrow depression—Vincristine—muscle cancer	0.00316	0.019	CcSEcCtD
Ranitidine—Nephropathy toxic—Etoposide—muscle cancer	0.00301	0.0181	CcSEcCtD
Ranitidine—Loss of libido—Methotrexate—muscle cancer	0.00224	0.0135	CcSEcCtD
Ranitidine—Aplastic anaemia—Dactinomycin—muscle cancer	0.00224	0.0135	CcSEcCtD
Ranitidine—Nephropathy—Methotrexate—muscle cancer	0.00217	0.0131	CcSEcCtD
Ranitidine—Musculoskeletal pain—Vincristine—muscle cancer	0.00216	0.013	CcSEcCtD
Ranitidine—Hepatic failure—Dactinomycin—muscle cancer	0.00193	0.0116	CcSEcCtD
Ranitidine—Hepatic failure—Vincristine—muscle cancer	0.00172	0.0104	CcSEcCtD
Ranitidine—Bone marrow depression—Methotrexate—muscle cancer	0.00153	0.00923	CcSEcCtD
Ranitidine—Liver disorder—Methotrexate—muscle cancer	0.00152	0.00914	CcSEcCtD
Ranitidine—Dysphagia—Dactinomycin—muscle cancer	0.0015	0.00902	CcSEcCtD
Ranitidine—Haematemesis—Methotrexate—muscle cancer	0.00149	0.00897	CcSEcCtD
Ranitidine—Cardiac arrest—Vincristine—muscle cancer	0.00147	0.00886	CcSEcCtD
Ranitidine—Serum creatinine increased—Doxorubicin—muscle cancer	0.00146	0.00877	CcSEcCtD
Ranitidine—Pancytopenia—Dactinomycin—muscle cancer	0.00142	0.00856	CcSEcCtD
Ranitidine—Neutropenia—Dactinomycin—muscle cancer	0.0014	0.00843	CcSEcCtD
Ranitidine—Pneumonia—Dactinomycin—muscle cancer	0.00134	0.00809	CcSEcCtD
Ranitidine—Bone marrow depression—Doxorubicin—muscle cancer	0.00133	0.00799	CcSEcCtD
Ranitidine—Haematemesis—Doxorubicin—muscle cancer	0.00129	0.00776	CcSEcCtD
Ranitidine—Pancytopenia—Vincristine—muscle cancer	0.00127	0.00765	CcSEcCtD
Ranitidine—Neutropenia—Vincristine—muscle cancer	0.00125	0.00753	CcSEcCtD
Ranitidine—Agranulocytosis—Dactinomycin—muscle cancer	0.00125	0.0075	CcSEcCtD
Ranitidine—Erectile dysfunction—Vincristine—muscle cancer	0.00123	0.00742	CcSEcCtD
Ranitidine—Photosensitivity reaction—Vincristine—muscle cancer	0.00122	0.00735	CcSEcCtD
Ranitidine—Weight decreased—Vincristine—muscle cancer	0.00121	0.00729	CcSEcCtD
Ranitidine—Pneumonia—Vincristine—muscle cancer	0.0012	0.00722	CcSEcCtD
Ranitidine—Hepatitis—Dactinomycin—muscle cancer	0.0012	0.00722	CcSEcCtD
Ranitidine—Cardiac arrest—Etoposide—muscle cancer	0.00119	0.00718	CcSEcCtD
Ranitidine—Sweating—Vincristine—muscle cancer	0.00114	0.00689	CcSEcCtD
Ranitidine—Erythema multiforme—Dactinomycin—muscle cancer	0.00113	0.00682	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00111	0.00666	CcSEcCtD
Ranitidine—Dysphagia—Etoposide—muscle cancer	0.00108	0.00653	CcSEcCtD
Ranitidine—Blood disorder—Doxorubicin—muscle cancer	0.00107	0.00646	CcSEcCtD
Ranitidine—Bronchospasm—Etoposide—muscle cancer	0.00107	0.00642	CcSEcCtD
Ranitidine—Hallucination—Vincristine—muscle cancer	0.00107	0.00642	CcSEcCtD
Ranitidine—Vasculitis—Methotrexate—muscle cancer	0.00106	0.00638	CcSEcCtD
Ranitidine—Alopecia—Dactinomycin—muscle cancer	0.00106	0.00638	CcSEcCtD
Ranitidine—Erythema—Dactinomycin—muscle cancer	0.00104	0.00628	CcSEcCtD
Ranitidine—Delirium—Doxorubicin—muscle cancer	0.00104	0.00627	CcSEcCtD
Ranitidine—Pancytopenia—Etoposide—muscle cancer	0.00103	0.0062	CcSEcCtD
Ranitidine—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00102	0.00614	CcSEcCtD
Ranitidine—Neutropenia—Etoposide—muscle cancer	0.00101	0.0061	CcSEcCtD
Ranitidine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.000992	0.00597	CcSEcCtD
Ranitidine—Pneumonia—Etoposide—muscle cancer	0.000972	0.00585	CcSEcCtD
Ranitidine—Aplastic anaemia—Methotrexate—muscle cancer	0.000972	0.00585	CcSEcCtD
Ranitidine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000968	0.00583	CcSEcCtD
Ranitidine—Anaemia—Dactinomycin—muscle cancer	0.000965	0.00581	CcSEcCtD
Ranitidine—Dyskinesia—Doxorubicin—muscle cancer	0.000954	0.00574	CcSEcCtD
Ranitidine—Alopecia—Vincristine—muscle cancer	0.000947	0.0057	CcSEcCtD
Ranitidine—Jaundice—Etoposide—muscle cancer	0.000942	0.00567	CcSEcCtD
Ranitidine—Malaise—Dactinomycin—muscle cancer	0.000941	0.00567	CcSEcCtD
Ranitidine—Leukopenia—Dactinomycin—muscle cancer	0.000934	0.00562	CcSEcCtD
Ranitidine—Gynaecomastia—Methotrexate—muscle cancer	0.000926	0.00557	CcSEcCtD
Ranitidine—Atrioventricular block—Doxorubicin—muscle cancer	0.000924	0.00556	CcSEcCtD
Ranitidine—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000907	0.00546	CcSEcCtD
Ranitidine—Agranulocytosis—Etoposide—muscle cancer	0.000902	0.00543	CcSEcCtD
Ranitidine—Hepatocellular injury—Doxorubicin—muscle cancer	0.000896	0.00539	CcSEcCtD
Ranitidine—Myalgia—Dactinomycin—muscle cancer	0.000889	0.00535	CcSEcCtD
Ranitidine—Dermatitis contact—Doxorubicin—muscle cancer	0.000886	0.00533	CcSEcCtD
Ranitidine—Discomfort—Dactinomycin—muscle cancer	0.000878	0.00528	CcSEcCtD
Ranitidine—Anaemia—Vincristine—muscle cancer	0.000862	0.00519	CcSEcCtD
Ranitidine—Agitation—Vincristine—muscle cancer	0.000857	0.00516	CcSEcCtD
Ranitidine—Photosensitivity—Methotrexate—muscle cancer	0.000856	0.00515	CcSEcCtD
Ranitidine—Aplastic anaemia—Doxorubicin—muscle cancer	0.000842	0.00506	CcSEcCtD
Ranitidine—Vertigo—Vincristine—muscle cancer	0.000838	0.00504	CcSEcCtD
Ranitidine—Hepatic failure—Methotrexate—muscle cancer	0.000836	0.00503	CcSEcCtD
Ranitidine—Leukopenia—Vincristine—muscle cancer	0.000835	0.00502	CcSEcCtD
Ranitidine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000834	0.00502	CcSEcCtD
Ranitidine—Erythema multiforme—Etoposide—muscle cancer	0.000821	0.00494	CcSEcCtD
Ranitidine—Myalgia—Vincristine—muscle cancer	0.000794	0.00478	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000776	0.00467	CcSEcCtD
Ranitidine—Alopecia—Etoposide—muscle cancer	0.000767	0.00462	CcSEcCtD
Ranitidine—Anaphylactic shock—Vincristine—muscle cancer	0.000761	0.00458	CcSEcCtD
Ranitidine—Thrombocytopenia—Vincristine—muscle cancer	0.000745	0.00449	CcSEcCtD
Ranitidine—Photosensitivity—Doxorubicin—muscle cancer	0.000741	0.00446	CcSEcCtD
Ranitidine—Hyperhidrosis—Vincristine—muscle cancer	0.000736	0.00443	CcSEcCtD
Ranitidine—Pain—Dactinomycin—muscle cancer	0.000728	0.00438	CcSEcCtD
Ranitidine—Hepatic failure—Doxorubicin—muscle cancer	0.000724	0.00436	CcSEcCtD
Ranitidine—Hypotension—Vincristine—muscle cancer	0.000711	0.00428	CcSEcCtD
Ranitidine—Feeling abnormal—Dactinomycin—muscle cancer	0.000702	0.00423	CcSEcCtD
Ranitidine—Ill-defined disorder—Etoposide—muscle cancer	0.000701	0.00422	CcSEcCtD
Ranitidine—Anaemia—Etoposide—muscle cancer	0.000698	0.0042	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000693	0.00417	CcSEcCtD
Ranitidine—Insomnia—Vincristine—muscle cancer	0.000688	0.00414	CcSEcCtD
Ranitidine—Malaise—Etoposide—muscle cancer	0.000681	0.0041	CcSEcCtD
Ranitidine—Breast disorder—Methotrexate—muscle cancer	0.000679	0.00409	CcSEcCtD
Ranitidine—Vertigo—Etoposide—muscle cancer	0.000679	0.00409	CcSEcCtD
Ranitidine—Leukopenia—Etoposide—muscle cancer	0.000676	0.00407	CcSEcCtD
Ranitidine—Abdominal pain—Dactinomycin—muscle cancer	0.000673	0.00405	CcSEcCtD
Ranitidine—Body temperature increased—Dactinomycin—muscle cancer	0.000673	0.00405	CcSEcCtD
Ranitidine—Constipation—Vincristine—muscle cancer	0.000651	0.00392	CcSEcCtD
Ranitidine—Pain—Vincristine—muscle cancer	0.000651	0.00392	CcSEcCtD
Ranitidine—Chest pain—Etoposide—muscle cancer	0.000643	0.00387	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—muscle cancer	0.000643	0.00387	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—muscle cancer	0.000637	0.00383	CcSEcCtD
Ranitidine—Discomfort—Etoposide—muscle cancer	0.000635	0.00382	CcSEcCtD
Ranitidine—Hypersensitivity—Dactinomycin—muscle cancer	0.000628	0.00378	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—muscle cancer	0.000623	0.00375	CcSEcCtD
Ranitidine—Confusional state—Etoposide—muscle cancer	0.000622	0.00374	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—muscle cancer	0.000619	0.00372	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—muscle cancer	0.000617	0.00371	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—muscle cancer	0.000617	0.00371	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—muscle cancer	0.00061	0.00367	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—muscle cancer	0.000607	0.00365	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—muscle cancer	0.000604	0.00363	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—muscle cancer	0.000602	0.00362	CcSEcCtD
Ranitidine—Abdominal pain—Vincristine—muscle cancer	0.000602	0.00362	CcSEcCtD
Ranitidine—Body temperature increased—Vincristine—muscle cancer	0.000602	0.00362	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—muscle cancer	0.000598	0.0036	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—muscle cancer	0.000596	0.00359	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000594	0.00358	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000593	0.00357	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—muscle cancer	0.000588	0.00354	CcSEcCtD
Ranitidine—Diarrhoea—Dactinomycin—muscle cancer	0.000583	0.00351	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—muscle cancer	0.000582	0.00351	CcSEcCtD
Ranitidine—Hypotension—Etoposide—muscle cancer	0.000576	0.00347	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000574	0.00345	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—muscle cancer	0.000562	0.00338	CcSEcCtD
Ranitidine—Hypersensitivity—Vincristine—muscle cancer	0.000561	0.00338	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—muscle cancer	0.000557	0.00335	CcSEcCtD
Ranitidine—Sweating—Methotrexate—muscle cancer	0.000555	0.00334	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—muscle cancer	0.000551	0.00332	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—muscle cancer	0.00055	0.00331	CcSEcCtD
Ranitidine—Somnolence—Etoposide—muscle cancer	0.000548	0.0033	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—muscle cancer	0.000548	0.0033	CcSEcCtD
Ranitidine—Vomiting—Dactinomycin—muscle cancer	0.000542	0.00326	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—muscle cancer	0.00054	0.00325	CcSEcCtD
Ranitidine—Rash—Dactinomycin—muscle cancer	0.000537	0.00323	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—muscle cancer	0.000534	0.00321	CcSEcCtD
Ranitidine—Pain—Etoposide—muscle cancer	0.000527	0.00317	CcSEcCtD
Ranitidine—Constipation—Etoposide—muscle cancer	0.000527	0.00317	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—muscle cancer	0.000526	0.00316	CcSEcCtD
Ranitidine—Diarrhoea—Vincristine—muscle cancer	0.000521	0.00313	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—muscle cancer	0.00052	0.00313	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000513	0.00309	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—muscle cancer	0.000509	0.00306	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—muscle cancer	0.000508	0.00306	CcSEcCtD
Ranitidine—Nausea—Dactinomycin—muscle cancer	0.000506	0.00305	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—muscle cancer	0.000504	0.00304	CcSEcCtD
Ranitidine—Dizziness—Vincristine—muscle cancer	0.000503	0.00303	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—muscle cancer	0.000491	0.00296	CcSEcCtD
Ranitidine—Urticaria—Etoposide—muscle cancer	0.00049	0.00295	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—muscle cancer	0.000489	0.00294	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—muscle cancer	0.000487	0.00293	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—muscle cancer	0.000487	0.00293	CcSEcCtD
Ranitidine—Vomiting—Vincristine—muscle cancer	0.000484	0.00291	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—muscle cancer	0.000481	0.00289	CcSEcCtD
Ranitidine—Rash—Vincristine—muscle cancer	0.00048	0.00289	CcSEcCtD
Ranitidine—Dermatitis—Vincristine—muscle cancer	0.000479	0.00289	CcSEcCtD
Ranitidine—Headache—Vincristine—muscle cancer	0.000477	0.00287	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—muscle cancer	0.000468	0.00282	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—muscle cancer	0.000459	0.00276	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—muscle cancer	0.000458	0.00276	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—muscle cancer	0.000454	0.00273	CcSEcCtD
Ranitidine—Erythema—Methotrexate—muscle cancer	0.000452	0.00272	CcSEcCtD
Ranitidine—Nausea—Vincristine—muscle cancer	0.000452	0.00272	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—muscle cancer	0.00045	0.00271	CcSEcCtD
Ranitidine—Pruritus—Etoposide—muscle cancer	0.000436	0.00263	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—muscle cancer	0.000426	0.00257	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—muscle cancer	0.000426	0.00256	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—muscle cancer	0.000422	0.00254	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—muscle cancer	0.00042	0.00253	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—muscle cancer	0.000418	0.00252	CcSEcCtD
Ranitidine—Malaise—Methotrexate—muscle cancer	0.000408	0.00246	CcSEcCtD
Ranitidine—Dizziness—Etoposide—muscle cancer	0.000408	0.00245	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—muscle cancer	0.000407	0.00245	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—muscle cancer	0.000405	0.00244	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—muscle cancer	0.000402	0.00242	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—muscle cancer	0.000398	0.00239	CcSEcCtD
Ranitidine—Vomiting—Etoposide—muscle cancer	0.000392	0.00236	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—muscle cancer	0.000392	0.00236	CcSEcCtD
Ranitidine—Rash—Etoposide—muscle cancer	0.000389	0.00234	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—muscle cancer	0.000388	0.00234	CcSEcCtD
Ranitidine—Headache—Etoposide—muscle cancer	0.000386	0.00232	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—muscle cancer	0.000385	0.00232	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—muscle cancer	0.000385	0.00232	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—muscle cancer	0.000385	0.00232	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—muscle cancer	0.000381	0.00229	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—muscle cancer	0.000372	0.00224	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—muscle cancer	0.000369	0.00222	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—muscle cancer	0.000369	0.00222	CcSEcCtD
Ranitidine—Nausea—Etoposide—muscle cancer	0.000366	0.0022	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000364	0.00219	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—muscle cancer	0.000362	0.00218	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—muscle cancer	0.000362	0.00218	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—muscle cancer	0.00036	0.00217	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000357	0.00215	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—muscle cancer	0.000353	0.00213	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—muscle cancer	0.000352	0.00212	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—muscle cancer	0.000351	0.00211	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—muscle cancer	0.000345	0.00208	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000336	0.00203	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—muscle cancer	0.000334	0.00201	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—muscle cancer	0.000334	0.00201	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—muscle cancer	0.000334	0.00201	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—muscle cancer	0.000334	0.00201	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—muscle cancer	0.00033	0.00198	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—muscle cancer	0.000329	0.00198	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—muscle cancer	0.000328	0.00198	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—muscle cancer	0.000322	0.00194	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00032	0.00192	CcSEcCtD
Ranitidine—Pain—Methotrexate—muscle cancer	0.000316	0.0019	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000313	0.00188	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—muscle cancer	0.000312	0.00188	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000309	0.00186	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—muscle cancer	0.000304	0.00183	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—muscle cancer	0.000299	0.0018	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—muscle cancer	0.000293	0.00177	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—muscle cancer	0.000292	0.00176	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—muscle cancer	0.000292	0.00176	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000291	0.00175	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—muscle cancer	0.000289	0.00174	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—muscle cancer	0.000285	0.00172	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—muscle cancer	0.000284	0.00171	CcSEcCtD
Ranitidine—Pain—Doxorubicin—muscle cancer	0.000273	0.00165	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—muscle cancer	0.000273	0.00165	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—muscle cancer	0.000272	0.00164	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000264	0.00159	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—muscle cancer	0.000261	0.00157	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—muscle cancer	0.000254	0.00153	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—muscle cancer	0.000253	0.00152	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—muscle cancer	0.000253	0.00152	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—muscle cancer	0.000253	0.00152	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—muscle cancer	0.000244	0.00147	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—muscle cancer	0.000236	0.00142	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—muscle cancer	0.000235	0.00141	CcSEcCtD
Ranitidine—Rash—Methotrexate—muscle cancer	0.000233	0.0014	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—muscle cancer	0.000233	0.0014	CcSEcCtD
Ranitidine—Headache—Methotrexate—muscle cancer	0.000231	0.00139	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—muscle cancer	0.000226	0.00136	CcSEcCtD
Ranitidine—Nausea—Methotrexate—muscle cancer	0.000219	0.00132	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—muscle cancer	0.000219	0.00132	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—muscle cancer	0.000211	0.00127	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—muscle cancer	0.000203	0.00122	CcSEcCtD
Ranitidine—Rash—Doxorubicin—muscle cancer	0.000202	0.00121	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—muscle cancer	0.000201	0.00121	CcSEcCtD
Ranitidine—Headache—Doxorubicin—muscle cancer	0.0002	0.00121	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—muscle cancer	0.00019	0.00114	CcSEcCtD
